Original Research Article
Year: 2022 | Month: February | Volume: 9 | Issue: 2 | Pages: 53-58
DOI: https://doi.org/10.52403/ijrr.20220209
Evaluating the Role of Suranjan in Combination with Sharbat-e-Bazoori for the Management of Gout
Arsheed Iqbal1, Afroz Jan2, Adil Rashid3, Zahoor Ahmed4, Arjumand5, Huma6
1Research Officer-Scientist III-Regional Research Institute of Unani Medicine,
Naseem Bagh, University of Kashmir, Srinagar, Jammu and Kashmir, India
2Assistant Professor Physiology, IAMS, India
3Lecturer Statistics, Gandhi Memorial College Srinagar, J & K
4P.G. Scholar, Regional Research Institute of Unani Medicine
5,6Research Officer (Unani) RRIUM, Srinagar, J& K, India
Corresponding Author: Arsheed Iqbal
ABSTRACT
Gout is metabolic disease that usually affects middle age and rarely elderly people. Clinically it is observed that this disease occurs due to intake of protein rich and high calorie diet. Pathologically deposition of mono-sodium urate crystals in joint space and other tissues results in the symptoms like pain and inflammation.
Methods: in this study, patients of gout are treated with soranjan tablet in combination with sharbat-e-Bazoori for a period of one month who qualified the inclusion criteria.
Results: we observed that severity of joint swelling, pain, inflammation, tenderness, stiffness and mobility resolved significantly after the treatment (p-value <0.0001*). All the objective parameters like; Sr. uric acid, ESR and CRP improved significantly after the treatment with a p-value (<0.0001*).
Conclusion: owing to the painful and stressful condition of the gout, it has been demonstrated that a combination of two Unani drugs (Habi Suranjan and Sharbat-e-Bazoori) together effectively treats gout and the associated symptoms.
Keywords: Gout, Uric acid, Niqras, Hyperuricemia.
[PDF Full Text]